Trial Profile
Randomised trial of surgical resection with or without pre-operative chemotherapy in patients with operable non-small lung cancer (NSCLC) of any stage.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2012
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary) ; Gemcitabine (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 02 Apr 2012 Actual end date (29 Jun 2005) added as reported by Netherlands Trial Register.
- 02 Apr 2012 Status changed from active, no longer recruiting to completed as reported by Netherlands Trial Register.
- 20 Mar 2007 New trial record.